keyword
https://read.qxmd.com/read/38652865/effect-of-tyrosine-kinase-inhibitors-on-male-fertility-in-patients-with-chronic-phase-chronic-myeloid-leukemia
#1
JOURNAL ARTICLE
George Nesr, Simone Claudiani, Dragana Milojkovic, Andrew Innes, Fiona Fernando, Irene Caballes, Patience Mungozi, Richard Szydlo, Silvia Lovato, Channa Jayasena, Jane Apperley
Advancements in the management of patients with chronic myeloid leukemia (CML) allowed them to achieve survival comparable with their healthy counterparts. Consequently, their care has widened with growing focus on quality of life, including parenting children. Although tyrosine kinase inhibitors (TKI) are contraindicated in pregnancy given their teratogenic effect, their effect on male fertility is less clear with contradictory results from animal studies and case reports/series. We compared the sperm analysis parameters, as the gold-standard assessment for male fertility, of 11 patients with CP- CML before and after TKI therapy...
April 23, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38652861/challenges-in-management-of-older-patients-with-chronic-myeloid-leukemia
#2
REVIEW
Jessica M Stempel, Rory M Shallis, Rong Wong, Nikolai A Podoltsev
Tyrosine kinase inhibitors (TKIs) have significantly improved the survival of patients with chronic myeloid leukemia (CML), however, older patients are often underrepresented in pivotal trials. Approximately 20% of older adults never start treatment and face significant barriers to accomplish favorable outcomes. The treatment goal is to improve survival, prevent progression, and preserve quality of life. This is achieved through optimizing TKI doses and employing discontinuation strategies to attain treatment-free remission (TFR), a goal increasingly pursued by older patients...
April 23, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38652836/an-analysis-of-the-effects-of-chronic-low-dose-rate-radiation-exposure-on-cancer-focusing-on-the-differences-among-cancer-types
#3
JOURNAL ARTICLE
Tetsuhiro Kinugawa, Ignacia Braga Tanaka, Satoshi Tanaka, Yuichiro Manabe, Fuminobu Sato, Takahiro Wada
PURPOSE: The effect of chronic low dose-rate radiation exposure on cancers was investigated by analyzing the data of mice experiments conducted at the Institute for Environmental Sciences (IES). This analysis focuses on the differences between malignant lymphomas and solid cancers. MATERIALS AND METHODS: The analysis is conducted based on the mathematical model introduced in our previous work. The model is expanded to analyze malignant lymphomas and solid cancers separately...
April 23, 2024: International Journal of Radiation Biology
https://read.qxmd.com/read/38652455/supportive-care-measures-for-bispecific-t-cell-engager-therapies-in-haematological-malignancies
#4
JOURNAL ARTICLE
Lucia Y Chen, Jaimal Kothari
PURPOSE OF REVIEW: Bispecific T-cell engager (TCE) therapies are revolutionizing the treatment of several haematological malignancies, including B-cell acute lymphoblastic leukaemia, various subtypes of B-cell non-Hodgkin lymphoma, and multiple myeloma. Due to their unique mode of action in activating endogenous T cells, they are associated with several important early side effects, including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, as well as target-specific toxicities and a significant risk of infection...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652335/combination-of-sj%C3%A3-gren-s-syndrome-and-anti-ku-syndrome-complicated-by-the-development-of-mucosa-associated-lymphoid-tissue-lymphoma-case-review-and-systematic-review-of-the-literature
#5
REVIEW
Oksana Andreevna Golovina, Anna Vasilievna Torgashina, Vadim Romanovich Gorodetskiy, Evgenia Vladimirovna Sockol, Elena Georgievna Sagina
The frequency of antibodies to Ku varies in various autoimmune diseases. In 2019, Spielmann et al. identified two types of anti-Ku syndrome based on a hierarchical clustering analysis. Sjögren's syndrome occurs both in the first type of anti-Ku syndrome and in the second type. Despite the fact that increased tissue expression of Ku proteins was noted in lymphocytic cells with focal sialoadenitis of the minor salivary glands in patients with primary Sjogren's syndrome, only 49 cases of a combination of anti-Ku antibodies and manifestations of Sjogren's syndrome have been described in the literature...
April 23, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38652119/long-term-remission-after-upfront-autologous-hematopoietic-stem-cell-transplant-for-cd5-diffuse-large-b-cell-lymphoma
#6
JOURNAL ARTICLE
Yosuke Masamoto, Akira Honda, Aya Shinozaki-Ushiku, Tetsuo Ushiku, Mineo Kurokawa
CD5+ diffuse large B-cell lymphoma (DLBCL) is a rare subtype characterized by an inferior outcome. While dose-dense therapy shows promising activity, the optimal management remains to be determined. To evaluate the benefit of consolidative autologous hematopoietic stem cell transplantation (ASCT), we retrospectively reviewed the medical records of 47 consecutive patients with newly diagnosed de novo CD5+ DLBCL. Of 19 patients ≤ 70 of age with age-adjusted International Prognostic Index 2-3, eight underwent upfront ASCT, and nine did not, despite preserved organ function and response after induction therapy...
April 23, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38651850/mycosis-fungoides-with-large-cell-transformation-cd30-and-b-cell-chronic-lymphocytic-leukemia
#7
JOURNAL ARTICLE
Mikela Petković, Ivana Ilić, Ružica Jurakić Tončić, Ivo Radman-Livaja, Romana Čeović
Mycosis fugnoides (MF) is an indolent cutaneous T-cell lymphoma (CTLC) and is the most common of all cutaneous lymphomas. An increased risk for developing a second primary malignancy in patients with CTCL has been described in several studies, with a range from 1.04 to 2.4 (1-4). Caucasian males are at higher risk for MF development. MF is often diagnosed at ages between 55 and 67 years, and second malignancy usually occurs 5 or 6 years after the diagnosis of MF was established (5). The most common second primary malignancies include non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), lung carcinoma, bladder carcinoma, and melanoma...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651844/cutaneous-t-cell-lymphomas-a-single-center-retrospective-analysis
#8
JOURNAL ARTICLE
Till Kaemmerer, Anne Guertler, Benjamin M Clanner-Engelshofen, Corbinian Fuchs, Lars Einar French, Markus Reinholz
INTRODUCTION: Cutaneous T-cell lymphomas (CTCLs) are rare diseases characterized by infiltration of malignant T-cells into the skin. We evaluated the prevalence, epidemiology, and therapy of CTCLs, focusing on its most well-known subtypes, namely mycosis fungoides (MF) and Sézary syndrome (SS). PATIENTS AND METHODS: We retrospectively analyzed the medical data of patients with a histologically confirmed diagnosis of CTCL presenting to our outpatient department during a 5-year period from January 2015 to December 2019...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651796/persistent-cytopenia-after-cd19-car-t-therapy-in-relapsed-refractory-dlbcl-patients-could-be-a-predictor-of-efficacy-and-side-effects
#9
JOURNAL ARTICLE
Jingyi Li, Juan Mu, Jia Wang, Xin Li, Qing Li, Yili Jiang, Rui Cui, Qi Deng
Hematological toxicity is a severe adverse event (AE) in anti-CD19 chimeric antigen receptor (CAR) T cell therapy for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). However, the pathophysiological mechanism underlying prolonged cytopenia and the relationship between persistent cytopenia, efficacy, and AEs after anti-CD19 CAR T cell therapy are unknown. Therefore, this study explored whether persistent cytopenia after anti-CD19 CAR T cell therapy in patients with R/R DLBCL can predict therapeutic efficacy and AEs...
2024: Cell Transplantation
https://read.qxmd.com/read/38651792/ruptured-baker-cyst-on-18f-fdg-pet-ct
#10
JOURNAL ARTICLE
Emilie Mariëtte de Groot, Martinus Johannes van Amerongen, Marieke Janneke Martine Ploegmakers, Ingrid Henrica Antonia Zegers, Anne Isabelle Juliette Arens
A 78-year-old woman with diffuse large B-cell lymphoma was referred for an 18F-FDG PET/CT to evaluate therapy response after 6 cycles of R-mini-CHOP. A new 18F-FDG accumulation was noticed medial in the upper part of the right lower leg, spreading along the medial head of the gastrocnemius muscle. The shaft-bow-looking curvature, arch sign, of 18F-FDG revealed a fluid collection on CT. This typical pattern and its specific location are indicative of a ruptured Baker's cyst. It can manifest in 1 or both legs...
April 19, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38651679/reclaiming-self-balancing-on-a-tightrope-across-time-a-grounded-theory-of-transition-to-survivorship-in-older-adult-blood-cancer-survivors
#11
JOURNAL ARTICLE
Sylvia K Wood
AIM: To develop a theoretical understanding of the transition to survivorship in older adult blood cancer survivors. DESIGN: Qualitative research employing Classic Glaserian Grounded Theory methods. METHODS: Purposive and theoretical sampling recruited 17 participants via Leukaemia & Lymphoma Society© Community webpages (65-83 years) from across the US and Canada. Data from individual semi-structured interviews using HIPPA-compliant Zoom© were analysed from September 2020 to March 2021...
April 23, 2024: Journal of Advanced Nursing
https://read.qxmd.com/read/38651449/ophthalmic-manifestations-in-patients-with-blood-malignancies
#12
REVIEW
Costanza Rossi, Alessandro Buizza, Giuseppe Alessio, Massimiliano Borselli, Andrea Taloni, Adriano Carnevali, Giovanna Carnovale Scalzo, Andrea Lucisano, Vincenzo Scorcia, Giuseppe Giannaccare
Ocular complications can occur in up to 90% of patients with blood malignancies. Such complications range from direct infiltration to local hemostatic imbalance and treatment-related toxicity. This narrative review is based on a systematic computerized search of the literature conducted until January 2024 and examines the common ocular complications associated with blood cancers. Ocular complications from primary disease include mass effects from ocular adnexal lymphomas and intraocular lymphomas, with B-cell lymphomas accounting for 95% of primary ocular presentations...
March 28, 2024: Hematology Reports
https://read.qxmd.com/read/38651430/surgical-outcomes-and-complications-of-custom-made-prostheses-in-upper-limb-oncological-reconstruction-a-systematic-review
#13
REVIEW
Camillo Fulchignoni, Silvia Pietramala, Ivo Lopez, Giovan Giuseppe Mazzella, Chiara Comisi, Carlo Perisano, Lorenzo Rocchi, Tommaso Greco
Bone tumors of the upper limb are a common cause of bone pain and pathological fractures in both old and young populations. Surgical reconstruction and limb salvage have become valid options for these patients despite this kind of surgery being challenging due to the need for wide bone resection and the involvement of surrounding soft tissues. Computer-assisted technology helps the surgeon in pre-operative planning and in designing customized implants. The aim of this study was to investigate the surgical outcomes and complications of custom-made prostheses in oncologic reconstruction of the upper limb and if they are reliable options for patients suffering from aggressive tumors...
April 11, 2024: Journal of Functional Morphology and Kinesiology
https://read.qxmd.com/read/38651155/genetic-prediction-of-causal-association-between-serum-bilirubin-and-hematologic-malignancies-a-two-sample-mendelian-randomized-and-bioinformatics-study
#14
JOURNAL ARTICLE
Lihua Lu, Luting Luo, Xiang Li, Wanying Liu, Boheng Wu, Qing Cai, Jiazheng Li, Yan Huang, Yanxin Chen, Yongzhi Zheng, Jianda Hu
INTRODUCTION: An increasing number of cohort studies have shown a correlation between serum bilirubin and tumors, but no definitive causal relationship has been established between serum bilirubin and hematological malignancies.Therefore, the aim of the present study was to assess the causal relationship of serum bilirubin, including total bilirubin (TBIL) and direct bilirubin (DBIL), with hematological malignancies, including leukemia, lymphoma, and myeloma. METHODS: We used a genome-wide association study (GWAS) collection of TBIL, DBIL, and hematological malignancies data...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650820/rare-thyroid-diseases-mimicking-or-concealing-primitive-thyroid-neoplasms-a-call-for-a-check-and-double-check-clinical-mindset
#15
Frederik Duhamel, Eric Balti, Wim Waelput, Steven Raeymaeckers, Guy Verfaillie, Ine Luyten, Corina E Andreescu
Clinical endocrinologists encounter in their practice patients with thyroid diseases on a daily basis. Still, diagnosis of rare structural thyroid disorders can be quite challenging. In some instances, they do not only impersonate but can also conceal, other conditions such as thyroid carcinomas. We describe a series of patients with structural thyroid disorders including 1) anaplastic thyroid carcinoma initially presenting with features of thyroid abscess; 2) unicentric hyaline vascular Castleman's disease of the thyroid embedded in a stroma of papillary thyroid carcinoma; and 3) primary thyroid lymphoma with a rapid and fulminant evolution...
March 2024: Curēus
https://read.qxmd.com/read/38650799/malignancy-associated-secondary-hemophagocytic-lymphohistiocytosis-mimicking-an-infection-a-case-report-and-review-of-the-literature
#16
Meenakshi Gopalakrishnan, Arunalini Ramanathan, Dhaarani Jayaraman, Sri Gayathri Shanmugam, Julius Xavier Scott
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hematological disorder of immune dysregulation associated with significant challenges in diagnosis and management. Described as primary HLH secondary to genetic defects or more commonly secondary to infections, it can also occur secondary to malignancy, i.e., malignancy-associated hemophagocytic lymphohistiocytosis (M-HLH). A five-year-old male child presented with left cervical adenopathy and a high-spiking fever for two weeks. He had pallor, anasarca, multiple enlarged and matted cervical lymph nodes, respiratory distress, and hepatomegaly...
March 2024: Curēus
https://read.qxmd.com/read/38650785/pyrexia-of-unknown-origin-caused-by-non-hodgkin-s-lymphoma-a-diagnostic-challenge-for-clinicians
#17
Hassan Hussain, Chaminda Janaka, Anne Sonali Rodrigo, Manojkumar Krishnan, Azra Hassan
Non-Hodgkin's lymphomas (NHLs) are a group of lymphoproliferative diseases that originate from different cell types, namely B cells, T cells, or natural killer cells. Herein, we report the case of a 69-year-old male patient who presented with a gradual-onset, intermittent, low-grade fever for four months and a right-sided neck lump for two months. On examination, a right-sided enlarged lymph node sized 1 × 1 cm2 was noted, which was mobile, hard in consistency, and non-tender. No other lymphadenopathy was noted in other parts of the body...
March 2024: Curēus
https://read.qxmd.com/read/38650598/new-therapies-for-relapsed-or-refractory-aggressive-b-cell-lymphoma-increase-survival-analysis-from-the-relinf-registry-of-the-geltamo-group
#18
JOURNAL ARTICLE
Mariana Bastos-Oreiro, Pau Abrisqueta, Antonio Gutierrez, Ana Jiménez Ubieto, Maria Poza, Paula Fernanez-Caldas, María José LLacer, Sonia Gonzalez de Villambrosia, Raúl Córdoba, Alberto López, Elena Ceballos, Belen Navarro, Ana Muntañola, Eva Donato, Eva Diez-Baeza, Lourdes Escoda, Hugo Luzardo, María José Peñarrubia, Daniel García Belmonte, Emilia Pardal, Claudia Lozada, Alejandro Martín García-Sancho
No abstract text is available yet for this article.
April 2024: HemaSphere
https://read.qxmd.com/read/38650582/discovery-science-highlights-from-the-17th-international-conference-on-malignant-lymphoma
#19
JOURNAL ARTICLE
Gabriela Forestieri, Joyce Marques de Almeida, Sara Napoli, Deborah Piffaretti, Chiara Tarantelli, Fangwen Zhang, Afua Adjeiwaa Mensah
No abstract text is available yet for this article.
May 2024: Hematological Oncology
https://read.qxmd.com/read/38650545/paediatric-cutaneous-lymphomas-including-rare-subtypes-a-40-year-experience-at-a-tertiary-referral-centre
#20
JOURNAL ARTICLE
Silvia Alberti-Violetti, Gianluca Avallone, Cristiana Colonna, Gianluca Tavoletti, Luigia Venegoni, Valentina Merlo, Stefano Cambiaghi, Angelo V Marzano, Emilio Berti, Riccardo Cavalli
BACKGROUND: Primary cutaneous lymphomas are neoplasms of the immune system with a distinct tropism for the skin and an absence of extracutaneous manifestations at the time of diagnosis. Studies focusing on cutaneous lymphomas in children and adolescents remain scarce and often do not encompass the rare subtypes. OBJECTIVES: To address this knowledge gap by describing the clinical, histological and molecular characteristics of a large group of paediatric patients affected by primary cutaneous lymphoma...
April 23, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
keyword
keyword
119302
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.